Supplier profile
Hexal AG
Every public-sector award we hold for this supplier, across Germany, from 20 Apr 2009 to 25 Jul 2026.
Awards won
350
all time
Attributed value
€1.2m
312 shared, unvalued
Buyers
56
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 53 | not attributable |
| GWQ ServicePlus AG | 42 | not attributable |
| Techniker Krankenkasse | 41 | €2 |
| IKK classic | 28 | €878k |
| AOK Nordost – Die Gesundheitskasse | 22 | not attributable |
| AOK Baden-Württemberg | 15 | not attributable |
| spectrumK GmbH | 14 | not attributable |
| AOK Bayern – Die Gesundheitskasse | 13 | not attributable |
| Deutsche Rentenversicherung Knappschaft-Bahn-See (KBS) | 12 | not attributable |
| Vergabestelle der AOK – Rheinland-Pfalz/Saarland – Die Gesundheitskasse | 12 | not attributable |
What they win
Awards
Showing 51–75 of 350 awards we hold
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 4 Dec 2024
- Germany – Pharmaceutical products – Ersatzkassen-Generika Nr. 21 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 13 Nov 2024
- Amoxicillin fest (EU) - TK, hkk, HEK (ATC-Code: J01CA04) ↗Techniker Krankenkasseshared awardawarded 13 Nov 2024
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 ↗PBMG eGawarded 11 Nov 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Abirateron (ausgenommen Wirkstärke 500 mg), ATC L02BX03 für die Zeit 01.10.2024 - 30.09.2026 ↗DAK-Gesundheitshared awardawarded 2 Oct 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ranibizumab, ATC S01LA04 für die Zeit 01.09.2024 - 31.08.2026 ↗DAK-Gesundheitshared awardawarded 2 Sept 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.08.2024 - 31.07.2026 ↗DAK-Gesundheitshared awardawarded 2 Aug 2024
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 (OBO) für die Zeit 01.08.2024 - 31.07.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Aug 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.08.2024 - 31.07.2026 ↗DAK-Gesundheitshared awardawarded 1 Aug 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 (OBO) für die Zeit 01.08.2024 - 31.07.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Aug 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 31 Jul 2024
- Germany – Pharmaceutical products – post_Arzneimittelausschreibung_2024 a ↗IKK classicshared awardawarded 27 Jul 2024
- 001 | Acetylsalicylsäure Tabletten magensaftresistent u.w. [3] [H] ↗IKK classicshared awardawarded 26 Jul 2024
- Germany – Pharmaceutical products – 31. Generikaausschreibung (2;3er) Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 9 Jul 2024
- Germany – Pharmaceutical products – 31. Generikaausschreibung (Antibiotika) - Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 9 Jul 2024
- Germany – Pharmaceutical products – 31. Generikaausschreibung (Sustainability) - Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 9 Jul 2024
- Germany – Pharmaceutical products – 31. Generikaausschreibung (1a) Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 9 Jul 2024
- Amoxicillin + Clavulansäure (FTA, EU) ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2024
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2024
- Anagrelid (HKP) ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2024
- 4-Hydroxybutansäure ↗GWQ ServicePlus AGshared awardawarded 8 Jul 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 26 Jun 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 12 Jun 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 8 May 2024
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 1.Juli 2024 ↗PBMG eGawarded 7 May 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Hexal AG (BG Hexal 1 A Pharma GbR)12 awards
- Hexal AG (BG ALIUD HEXAL Viatris GbR)4 awards
- Hexal AG (BG Glenmark Hexal GbR)3 awards
- Hexal AG (BG Hexal 1 A Pharma)2 awards
- Hexal AG (BG Zentiva/Aristo/Hexal GbR)2 awards
- Hexal AG (BG ALIUD HEXAL 1 A PHARMA GbR)1 award
- Hexal AG (BG ALIUD/Hexal/Mylan GbR)1 award
- Hexal AG (BG Aristo Hexal Zentiva GbR)1 award
- Hexal AG (BG TEVA/Hexal GbR)1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.